文献速递眼底病与葡萄膜炎

地图状萎缩病灶前沿位移定量评估萎缩进展

Quantitative Evaluation of Geographic Atrophy Progression Using Geographic Atrophy Lesion Front Displacement.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该回顾性纵向分析纳入MAHALO临床试验中103只未经治疗的对侧眼,随访18个月,评估基于边界的病灶前沿位移指标在量化年龄相关性黄斑变性所致地图状萎缩进展中的表现。结果显示病灶前沿位移较总面积的平方根变化等传统指标具有更好的线性拟合和更低的变异性,可作为纵向评估地图状萎缩进展的补充指标。

要点

  • 病灶前沿位移在18个月内呈现线性进展,而面积和平方根面积变化未通过线性检验。
  • 病灶前沿位移的决定系数R2=0.504,高于面积(0.116)、平方根面积(0.104)、周长(0.001)和λ'PA(0.018)。
  • 病灶前沿位移在12和18个月时的变异性显著低于周长变化和λ'PA(P<0.05)。

核心结论

  • 病灶前沿位移较几种传统地图状萎缩进展指标具有更一致的线性近似和更低的变异性。
  • 基于边界的病灶前沿位移可作为纵向评估地图状萎缩进展的补充指标。

研究设计与样本

  • 回顾性纵向分析,纳入MAHALO临床试验中103只未经治疗的对侧眼,均有地图状萎缩并完成18个月随访。
  • 在基线及第6、12、18个月获取眼底自发荧光图像,计算五种进展指标:总面积变化、面积平方根变化、总周长变化、周长调整增长率(λ'PA)和病灶前沿位移。
  • 采用简单线性回归和Harvey-Collier检验评估线性,采用标准差、方差比和Fligner-Killeen检验评估变异性。

主要发现

  • 面积和面积平方根变化的线性被拒绝,而病灶前沿位移、周长变化和λ'PA的线性未被拒绝。
  • 病灶前沿位移的决定系数R2=0.504,面积0.116、面积平方根0.104、周长0.001、λ'PA 0.018,均较低。
  • 病灶前沿位移在各随访间期表现出较低的离散度。
  • 方差比分析表明所有对照指标的变异性均更大。
  • 病灶前沿位移的变异性在12和18个月时显著低于周长变化和λ'PA(P<0.05)。

临床怎么用

  • 在纵向评估地图状萎缩进展时,可考虑将病灶前沿位移作为补充指标,因其线性更好且变异性更低。
  • 传统面积或平方根面积指标可能因非线性进展而影响长期变化评估的稳定性。

局限性

  • 本研究为回顾性分析,样本来自MAHALO临床试验中未经治疗的对侧眼,结果外推需谨慎。
  • 随访时间为18个月,更长随访期下的表现未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the temporal behavior and relative variability of a margin-based metric, lesion front displacement, for quantifying geographic atrophy (GA) progression secondary to age-related macular degeneration and to compare its performance with conventional metrics. METHODS: This retrospective longitudinal analysis included 103 untreated fellow eyes from the MAHALO clinical trial with GA and 18-month follow-up. Fundus autofluorescence images were obtained at baseline and 6, 12, and 18 months. Five progression metrics were calculated: total area change, square root area change, total perimeter change, perimeter-adjusted growth rate (λ'PA), and lesion front displacement. Linearity was assessed using simple linear regression and the Harvey-Collier test. Variability was evaluated using standard deviation, variance ratios, and the Fligner-Killeen test. RESULTS: Linearity was rejected for area and square root area change but not for lesion front displacement, perimeter change, or λ'PA. Lesion front displacement showed a relatively higher coefficient of determination (R2 = 0.504), whereas area (0.116), square root area (0.104), perimeter (0.001), and λ'PA (0.018) exhibited lower goodness of fit to a linear model. Lesion front displacement demonstrated lower dispersion across follow-up intervals. Variance ratio analysis indicated greater variability for all comparator metrics. Variability was significantly lower for lesion front displacement than for perimeter change and λ'PA at 12 and 18 months (P < 0.05). CONCLUSIONS: Lesion front displacement demonstrated more consistent linear approximation and lower variability compared with several conventional GA progression metrics. This margin-based approach may serve as a complementary metric for longitudinal assessment of GA progression.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chujo S, Baek J, Uji A, et al. Quantitative Evaluation of Geographic Atrophy Progression Using Geographic Atrophy Lesion Front Displacement. Invest Ophthalmol Vis Sci. 2026. PMID: 42536362. doi:10.1167/iovs.67.8.64

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。